Ignite Creation Date:
2025-12-25 @ 1:14 AM
Ignite Modification Date:
2026-02-23 @ 8:56 PM
Study NCT ID:
NCT01738893
Status:
COMPLETED
Last Update Posted:
2017-06-20
First Post:
2012-11-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study of 300 mg Gabapentin
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01-14
Start Date Type:
ACTUAL
Primary Completion Date:
2011-01-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-01-22
Completion Date Type:
ACTUAL
First Submit Date:
2012-11-28
First Submit QC Date:
None
Study First Post Date:
2012-11-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-19
Last Update Post Date:
2017-06-20
Last Update Post Date Type:
ACTUAL